Dave Schubert

Professor and Laboratory Head

Cellular Neurobiology Laboratory

Salk Institute for Biological Studies - Videos

Videos


Salk scientists develop drug that slows Alzheimer’s

Findings may lead to first therapeutic drug to treat advanced Alzheimer’s.

A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer’s disease in aged mice following short-term treatment. The findings, published May 14 in the journal Alzheimer’s Research and Therapy, may pave the way to a new treatment for Alzheimer’s disease in humans. Read more »


Alzheimer’s drug candidate may be first to prevent disease progression

A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer’s disease, based on the findings of a study published in PLoS ONE.

When given to mice with Alzheimer’s, the drug, known as J147, improved memory and prevented brain damage caused by the disease. The new compound, developed by scientists at the Salk Institute for Biological Studies, could be tested for treatment of the disease in humans in the near future. Read more »


Education

BA, Chemistry, Indiana University
Graduate student with Mel Cohn, Salk Institute
PhD, Cell Biology, UCSD
Postdoctoral Fellow, Cell Biology, Nobel Laureate Francois Jacob, Pasteur Institute, Paris


Awards & Honors

  • 1993 Jacob Javits Award
  • Zenith Award, Alzheimer's Association
  • 1986 Jacob Javits Award

Science Guide